Enabling Sequencing Anywhere - by Anyone

NEXT Generation Sequencing is moving to point-of-need

Next-generation sequencing (NGS) is increasingly shifting toward point-of-need applications due to the demand for faster results and the desire to conduct tests on-site. Sequencing and analysis can be carried out using portable, low-cost equipment. Oxford Nanopore Technologies has the first portable low-cost sequencer on the market. However, the complexity of sample processing remains a significant challenge, confining its use to specialized labs and hindering its adoption for point-of-need scenarios. Until now, sample processing technology has lagged behind the need. 

Step 1: Collect Sample

Step 2: Prep Sample

Step 3: Sequence Sample

Step 4: Interpret Results

Genomics Applications Developing at a Rapid Pace

The genomics research market is rapidly growing and is projected to reach $157B by 2030. Much like the technological advances that put the power of the mainframe computer in a smartphone, we cannot begin to imagine the advances that accessible, low-cost tools for genomics research will enable.

Agnostic Diagnostics

Identify any viral or bacterial infection, including novel pathogens, and determine antibiotic resistance

Cancer

Blood biopsies can identify a wide variety of cancers at an early stage from a blood sample

Neurodegenerative Diseases

Early identification of Alzheimer’s to enable early treatment to delay disease progression

Addressing today’s gap and enabling tomorrow’s applications

Today, most DNA sequencing is done manually in the lab or on high-throughput robotic machines that cost hundreds of thousands in capital investment, making many promising applications impractical or out of reach.

NEXT Labs is working toward affordable and portable solutions for sample and library prep, which will eliminate costly and manual lab work and enable point-of-care applications.

Shown with ONT’s MinION Sequencer

Request a Briefing

Interested in collaborating on an upcoming study? We welcome inquiries from researchers, potential investors or partners.